nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—ABCB1—Tamoxifen—pancreatic cancer	0.0728	0.199	CbGbCtD
Scopolamine—ABCB1—Gemcitabine—pancreatic cancer	0.0627	0.172	CbGbCtD
Scopolamine—ABCB1—Erlotinib—pancreatic cancer	0.0619	0.169	CbGbCtD
Scopolamine—ABCB1—Irinotecan—pancreatic cancer	0.0559	0.153	CbGbCtD
Scopolamine—ABCB1—Docetaxel—pancreatic cancer	0.041	0.112	CbGbCtD
Scopolamine—ABCB1—Sunitinib—pancreatic cancer	0.0408	0.112	CbGbCtD
Scopolamine—ABCB1—Doxorubicin—pancreatic cancer	0.0305	0.0835	CbGbCtD
Scopolamine—Sweating—Irinotecan—pancreatic cancer	0.00152	0.00445	CcSEcCtD
Scopolamine—Mental disorder—Sunitinib—pancreatic cancer	0.00151	0.00443	CcSEcCtD
Scopolamine—Erythema—Sunitinib—pancreatic cancer	0.0015	0.00441	CcSEcCtD
Scopolamine—Sweating—Gemcitabine—pancreatic cancer	0.00148	0.00434	CcSEcCtD
Scopolamine—Conjunctivitis—Fluorouracil—pancreatic cancer	0.00148	0.00432	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00147	0.0043	CcSEcCtD
Scopolamine—Dry mouth—Tamoxifen—pancreatic cancer	0.00146	0.00428	CcSEcCtD
Scopolamine—Bradycardia—Irinotecan—pancreatic cancer	0.00145	0.00424	CcSEcCtD
Scopolamine—Oedema—Tamoxifen—pancreatic cancer	0.00143	0.0042	CcSEcCtD
Scopolamine—Oedema—Erlotinib—pancreatic cancer	0.00142	0.00415	CcSEcCtD
Scopolamine—Nervous system disorder—Erlotinib—pancreatic cancer	0.00139	0.00407	CcSEcCtD
Scopolamine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00139	0.00406	CcSEcCtD
Scopolamine—Skin disorder—Erlotinib—pancreatic cancer	0.00138	0.00403	CcSEcCtD
Scopolamine—Pharyngitis—Gemcitabine—pancreatic cancer	0.00138	0.00403	CcSEcCtD
Scopolamine—Visual impairment—Irinotecan—pancreatic cancer	0.00137	0.00402	CcSEcCtD
Scopolamine—Urinary tract disorder—Gemcitabine—pancreatic cancer	0.00137	0.00401	CcSEcCtD
Scopolamine—Urethral disorder—Gemcitabine—pancreatic cancer	0.00136	0.00398	CcSEcCtD
Scopolamine—Pharyngitis—Fluorouracil—pancreatic cancer	0.00135	0.00396	CcSEcCtD
Scopolamine—Flushing—Irinotecan—pancreatic cancer	0.00132	0.00387	CcSEcCtD
Scopolamine—Dry skin—Docetaxel—pancreatic cancer	0.0013	0.00382	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.00127	0.00372	CcSEcCtD
Scopolamine—Arrhythmia—Irinotecan—pancreatic cancer	0.00127	0.00372	CcSEcCtD
Scopolamine—Dry mouth—Sunitinib—pancreatic cancer	0.00125	0.00367	CcSEcCtD
Scopolamine—Arrhythmia—Gemcitabine—pancreatic cancer	0.00124	0.00363	CcSEcCtD
Scopolamine—Fatigue—Tamoxifen—pancreatic cancer	0.00124	0.00362	CcSEcCtD
Scopolamine—Dysphagia—Docetaxel—pancreatic cancer	0.00123	0.0036	CcSEcCtD
Scopolamine—Oedema—Sunitinib—pancreatic cancer	0.00123	0.0036	CcSEcCtD
Scopolamine—Pain—Tamoxifen—pancreatic cancer	0.00123	0.00359	CcSEcCtD
Scopolamine—Constipation—Tamoxifen—pancreatic cancer	0.00123	0.00359	CcSEcCtD
Scopolamine—Fatigue—Erlotinib—pancreatic cancer	0.00122	0.00358	CcSEcCtD
Scopolamine—Dry eye—Epirubicin—pancreatic cancer	0.00122	0.00357	CcSEcCtD
Scopolamine—Arrhythmia—Fluorouracil—pancreatic cancer	0.00122	0.00357	CcSEcCtD
Scopolamine—Pain—Erlotinib—pancreatic cancer	0.00121	0.00355	CcSEcCtD
Scopolamine—Constipation—Erlotinib—pancreatic cancer	0.00121	0.00355	CcSEcCtD
Scopolamine—Erythema—Gemcitabine—pancreatic cancer	0.00121	0.00353	CcSEcCtD
Scopolamine—Nervous system disorder—Sunitinib—pancreatic cancer	0.0012	0.00353	CcSEcCtD
Scopolamine—Skin disorder—Sunitinib—pancreatic cancer	0.00119	0.00349	CcSEcCtD
Scopolamine—Erythema—Fluorouracil—pancreatic cancer	0.00119	0.00348	CcSEcCtD
Scopolamine—Abdominal pain—Tamoxifen—pancreatic cancer	0.00113	0.00332	CcSEcCtD
Scopolamine—Dry eye—Doxorubicin—pancreatic cancer	0.00113	0.00331	CcSEcCtD
Scopolamine—Abdominal pain—Erlotinib—pancreatic cancer	0.00112	0.00328	CcSEcCtD
Scopolamine—Body temperature increased—Erlotinib—pancreatic cancer	0.00112	0.00328	CcSEcCtD
Scopolamine—Vision blurred—Fluorouracil—pancreatic cancer	0.00112	0.00328	CcSEcCtD
Scopolamine—Vertigo—Irinotecan—pancreatic cancer	0.00111	0.00326	CcSEcCtD
Scopolamine—Eczema—Epirubicin—pancreatic cancer	0.00107	0.00313	CcSEcCtD
Scopolamine—Conjunctivitis—Docetaxel—pancreatic cancer	0.00107	0.00312	CcSEcCtD
Scopolamine—Fatigue—Sunitinib—pancreatic cancer	0.00106	0.0031	CcSEcCtD
Scopolamine—Constipation—Sunitinib—pancreatic cancer	0.00105	0.00307	CcSEcCtD
Scopolamine—Pain—Sunitinib—pancreatic cancer	0.00105	0.00307	CcSEcCtD
Scopolamine—Asthenia—Tamoxifen—pancreatic cancer	0.00103	0.00301	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00102	0.00299	CcSEcCtD
Scopolamine—Confusional state—Irinotecan—pancreatic cancer	0.00102	0.00299	CcSEcCtD
Scopolamine—Asthenia—Erlotinib—pancreatic cancer	0.00102	0.00298	CcSEcCtD
Scopolamine—Pruritus—Tamoxifen—pancreatic cancer	0.00101	0.00297	CcSEcCtD
Scopolamine—Oedema—Irinotecan—pancreatic cancer	0.00101	0.00296	CcSEcCtD
Scopolamine—Pruritus—Erlotinib—pancreatic cancer	0.001	0.00294	CcSEcCtD
Scopolamine—Nervous system disorder—Irinotecan—pancreatic cancer	0.000991	0.0029	CcSEcCtD
Scopolamine—Eczema—Doxorubicin—pancreatic cancer	0.000987	0.00289	CcSEcCtD
Scopolamine—Oedema—Gemcitabine—pancreatic cancer	0.000985	0.00288	CcSEcCtD
Scopolamine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000977	0.00286	CcSEcCtD
Scopolamine—Confusional state—Fluorouracil—pancreatic cancer	0.000976	0.00286	CcSEcCtD
Scopolamine—Pharyngitis—Docetaxel—pancreatic cancer	0.000976	0.00286	CcSEcCtD
Scopolamine—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000971	0.00285	CcSEcCtD
Scopolamine—Abdominal pain—Sunitinib—pancreatic cancer	0.00097	0.00284	CcSEcCtD
Scopolamine—Body temperature increased—Sunitinib—pancreatic cancer	0.00097	0.00284	CcSEcCtD
Scopolamine—Oedema—Fluorouracil—pancreatic cancer	0.000968	0.00284	CcSEcCtD
Scopolamine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000966	0.00283	CcSEcCtD
Scopolamine—Urethral disorder—Docetaxel—pancreatic cancer	0.000964	0.00282	CcSEcCtD
Scopolamine—Skin disorder—Gemcitabine—pancreatic cancer	0.000957	0.0028	CcSEcCtD
Scopolamine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000952	0.00279	CcSEcCtD
Scopolamine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00095	0.00278	CcSEcCtD
Scopolamine—Visual impairment—Docetaxel—pancreatic cancer	0.000948	0.00278	CcSEcCtD
Scopolamine—Dizziness—Tamoxifen—pancreatic cancer	0.000948	0.00278	CcSEcCtD
Scopolamine—Tachycardia—Fluorouracil—pancreatic cancer	0.000945	0.00277	CcSEcCtD
Scopolamine—Hypotension—Irinotecan—pancreatic cancer	0.000945	0.00277	CcSEcCtD
Scopolamine—Dizziness—Erlotinib—pancreatic cancer	0.000938	0.00275	CcSEcCtD
Scopolamine—Hypotension—Gemcitabine—pancreatic cancer	0.00092	0.0027	CcSEcCtD
Scopolamine—Eye disorder—Docetaxel—pancreatic cancer	0.000919	0.00269	CcSEcCtD
Scopolamine—Flushing—Docetaxel—pancreatic cancer	0.000913	0.00267	CcSEcCtD
Scopolamine—Vomiting—Tamoxifen—pancreatic cancer	0.000911	0.00267	CcSEcCtD
Scopolamine—Hypotension—Fluorouracil—pancreatic cancer	0.000905	0.00265	CcSEcCtD
Scopolamine—Rash—Tamoxifen—pancreatic cancer	0.000904	0.00265	CcSEcCtD
Scopolamine—Dermatitis—Tamoxifen—pancreatic cancer	0.000903	0.00264	CcSEcCtD
Scopolamine—Vomiting—Erlotinib—pancreatic cancer	0.000901	0.00264	CcSEcCtD
Scopolamine—Somnolence—Irinotecan—pancreatic cancer	0.000899	0.00263	CcSEcCtD
Scopolamine—Headache—Tamoxifen—pancreatic cancer	0.000898	0.00263	CcSEcCtD
Scopolamine—Rash—Erlotinib—pancreatic cancer	0.000894	0.00262	CcSEcCtD
Scopolamine—Dermatitis—Erlotinib—pancreatic cancer	0.000893	0.00262	CcSEcCtD
Scopolamine—Headache—Erlotinib—pancreatic cancer	0.000888	0.0026	CcSEcCtD
Scopolamine—Asthenia—Sunitinib—pancreatic cancer	0.000881	0.00258	CcSEcCtD
Scopolamine—Dry skin—Epirubicin—pancreatic cancer	0.000879	0.00258	CcSEcCtD
Scopolamine—Arrhythmia—Docetaxel—pancreatic cancer	0.000879	0.00257	CcSEcCtD
Scopolamine—Somnolence—Gemcitabine—pancreatic cancer	0.000875	0.00256	CcSEcCtD
Scopolamine—Fatigue—Irinotecan—pancreatic cancer	0.000872	0.00255	CcSEcCtD
Scopolamine—Pruritus—Sunitinib—pancreatic cancer	0.000868	0.00254	CcSEcCtD
Scopolamine—Pain—Irinotecan—pancreatic cancer	0.000865	0.00253	CcSEcCtD
Scopolamine—Constipation—Irinotecan—pancreatic cancer	0.000865	0.00253	CcSEcCtD
Scopolamine—Mental disorder—Docetaxel—pancreatic cancer	0.000862	0.00252	CcSEcCtD
Scopolamine—Somnolence—Fluorouracil—pancreatic cancer	0.000861	0.00252	CcSEcCtD
Scopolamine—Erythema—Docetaxel—pancreatic cancer	0.000856	0.00251	CcSEcCtD
Scopolamine—Nausea—Tamoxifen—pancreatic cancer	0.000851	0.00249	CcSEcCtD
Scopolamine—Fatigue—Gemcitabine—pancreatic cancer	0.000849	0.00249	CcSEcCtD
Scopolamine—Muscular weakness—Epirubicin—pancreatic cancer	0.000846	0.00248	CcSEcCtD
Scopolamine—Constipation—Gemcitabine—pancreatic cancer	0.000842	0.00247	CcSEcCtD
Scopolamine—Pain—Gemcitabine—pancreatic cancer	0.000842	0.00247	CcSEcCtD
Scopolamine—Nausea—Erlotinib—pancreatic cancer	0.000842	0.00247	CcSEcCtD
Scopolamine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000833	0.00244	CcSEcCtD
Scopolamine—Dysphagia—Epirubicin—pancreatic cancer	0.000829	0.00243	CcSEcCtD
Scopolamine—Pain—Fluorouracil—pancreatic cancer	0.000828	0.00243	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—pancreatic cancer	0.000813	0.00238	CcSEcCtD
Scopolamine—Dizziness—Sunitinib—pancreatic cancer	0.000812	0.00238	CcSEcCtD
Scopolamine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000812	0.00238	CcSEcCtD
Scopolamine—Body temperature increased—Irinotecan—pancreatic cancer	0.000799	0.00234	CcSEcCtD
Scopolamine—Abdominal pain—Irinotecan—pancreatic cancer	0.000799	0.00234	CcSEcCtD
Scopolamine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000798	0.00234	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000783	0.00229	CcSEcCtD
Scopolamine—Vomiting—Sunitinib—pancreatic cancer	0.00078	0.00229	CcSEcCtD
Scopolamine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000779	0.00228	CcSEcCtD
Scopolamine—Dysuria—Epirubicin—pancreatic cancer	0.000775	0.00227	CcSEcCtD
Scopolamine—Rash—Sunitinib—pancreatic cancer	0.000774	0.00227	CcSEcCtD
Scopolamine—Dermatitis—Sunitinib—pancreatic cancer	0.000773	0.00226	CcSEcCtD
Scopolamine—Headache—Sunitinib—pancreatic cancer	0.000769	0.00225	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—pancreatic cancer	0.000767	0.00225	CcSEcCtD
Scopolamine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000765	0.00224	CcSEcCtD
Scopolamine—Drowsiness—Epirubicin—pancreatic cancer	0.000739	0.00217	CcSEcCtD
Scopolamine—Nausea—Sunitinib—pancreatic cancer	0.000729	0.00214	CcSEcCtD
Scopolamine—Asthenia—Irinotecan—pancreatic cancer	0.000725	0.00212	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000724	0.00212	CcSEcCtD
Scopolamine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000718	0.0021	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—pancreatic cancer	0.000717	0.0021	CcSEcCtD
Scopolamine—Dry mouth—Docetaxel—pancreatic cancer	0.000713	0.00209	CcSEcCtD
Scopolamine—Sweating—Epirubicin—pancreatic cancer	0.000709	0.00208	CcSEcCtD
Scopolamine—Asthenia—Gemcitabine—pancreatic cancer	0.000707	0.00207	CcSEcCtD
Scopolamine—Confusional state—Docetaxel—pancreatic cancer	0.000705	0.00206	CcSEcCtD
Scopolamine—Oedema—Docetaxel—pancreatic cancer	0.000699	0.00205	CcSEcCtD
Scopolamine—Pruritus—Gemcitabine—pancreatic cancer	0.000697	0.00204	CcSEcCtD
Scopolamine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000685	0.00201	CcSEcCtD
Scopolamine—Pruritus—Fluorouracil—pancreatic cancer	0.000685	0.00201	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—pancreatic cancer	0.000684	0.002	CcSEcCtD
Scopolamine—Tachycardia—Docetaxel—pancreatic cancer	0.000682	0.002	CcSEcCtD
Scopolamine—Skin disorder—Docetaxel—pancreatic cancer	0.000679	0.00199	CcSEcCtD
Scopolamine—Bradycardia—Epirubicin—pancreatic cancer	0.000675	0.00198	CcSEcCtD
Scopolamine—Dizziness—Irinotecan—pancreatic cancer	0.000669	0.00196	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000665	0.00195	CcSEcCtD
Scopolamine—Pharyngitis—Epirubicin—pancreatic cancer	0.000659	0.00193	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—pancreatic cancer	0.000656	0.00192	CcSEcCtD
Scopolamine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000655	0.00192	CcSEcCtD
Scopolamine—Hypotension—Docetaxel—pancreatic cancer	0.000653	0.00191	CcSEcCtD
Scopolamine—Urethral disorder—Epirubicin—pancreatic cancer	0.00065	0.00191	CcSEcCtD
Scopolamine—Vomiting—Irinotecan—pancreatic cancer	0.000643	0.00188	CcSEcCtD
Scopolamine—Dizziness—Fluorouracil—pancreatic cancer	0.00064	0.00188	CcSEcCtD
Scopolamine—Visual impairment—Epirubicin—pancreatic cancer	0.000639	0.00187	CcSEcCtD
Scopolamine—Rash—Irinotecan—pancreatic cancer	0.000637	0.00187	CcSEcCtD
Scopolamine—Dermatitis—Irinotecan—pancreatic cancer	0.000637	0.00187	CcSEcCtD
Scopolamine—Headache—Irinotecan—pancreatic cancer	0.000633	0.00186	CcSEcCtD
Scopolamine—Vomiting—Gemcitabine—pancreatic cancer	0.000626	0.00183	CcSEcCtD
Scopolamine—Bradycardia—Doxorubicin—pancreatic cancer	0.000625	0.00183	CcSEcCtD
Scopolamine—Somnolence—Docetaxel—pancreatic cancer	0.000621	0.00182	CcSEcCtD
Scopolamine—Rash—Gemcitabine—pancreatic cancer	0.000621	0.00182	CcSEcCtD
Scopolamine—Dermatitis—Gemcitabine—pancreatic cancer	0.00062	0.00182	CcSEcCtD
Scopolamine—Eye disorder—Epirubicin—pancreatic cancer	0.00062	0.00182	CcSEcCtD
Scopolamine—Headache—Gemcitabine—pancreatic cancer	0.000617	0.00181	CcSEcCtD
Scopolamine—Flushing—Epirubicin—pancreatic cancer	0.000616	0.0018	CcSEcCtD
Scopolamine—Vomiting—Fluorouracil—pancreatic cancer	0.000616	0.0018	CcSEcCtD
Scopolamine—Rash—Fluorouracil—pancreatic cancer	0.000611	0.00179	CcSEcCtD
Scopolamine—Dermatitis—Fluorouracil—pancreatic cancer	0.00061	0.00179	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000609	0.00178	CcSEcCtD
Scopolamine—Headache—Fluorouracil—pancreatic cancer	0.000607	0.00178	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000606	0.00178	CcSEcCtD
Scopolamine—Fatigue—Docetaxel—pancreatic cancer	0.000603	0.00177	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000602	0.00176	CcSEcCtD
Scopolamine—Nausea—Irinotecan—pancreatic cancer	0.000601	0.00176	CcSEcCtD
Scopolamine—Pain—Docetaxel—pancreatic cancer	0.000598	0.00175	CcSEcCtD
Scopolamine—Constipation—Docetaxel—pancreatic cancer	0.000598	0.00175	CcSEcCtD
Scopolamine—Arrhythmia—Epirubicin—pancreatic cancer	0.000593	0.00174	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—pancreatic cancer	0.000592	0.00173	CcSEcCtD
Scopolamine—Nausea—Gemcitabine—pancreatic cancer	0.000585	0.00171	CcSEcCtD
Scopolamine—Mental disorder—Epirubicin—pancreatic cancer	0.000581	0.0017	CcSEcCtD
Scopolamine—Erythema—Epirubicin—pancreatic cancer	0.000578	0.00169	CcSEcCtD
Scopolamine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000576	0.00169	CcSEcCtD
Scopolamine—Nausea—Fluorouracil—pancreatic cancer	0.000575	0.00168	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—pancreatic cancer	0.000574	0.00168	CcSEcCtD
Scopolamine—Flushing—Doxorubicin—pancreatic cancer	0.00057	0.00167	CcSEcCtD
Scopolamine—Abdominal pain—Docetaxel—pancreatic cancer	0.000552	0.00162	CcSEcCtD
Scopolamine—Body temperature increased—Docetaxel—pancreatic cancer	0.000552	0.00162	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000548	0.00161	CcSEcCtD
Scopolamine—Vision blurred—Epirubicin—pancreatic cancer	0.000544	0.00159	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—pancreatic cancer	0.000538	0.00158	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—pancreatic cancer	0.000534	0.00157	CcSEcCtD
Scopolamine—Agitation—Epirubicin—pancreatic cancer	0.000531	0.00155	CcSEcCtD
Scopolamine—Vertigo—Epirubicin—pancreatic cancer	0.000519	0.00152	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—pancreatic cancer	0.000504	0.00148	CcSEcCtD
Scopolamine—Asthenia—Docetaxel—pancreatic cancer	0.000501	0.00147	CcSEcCtD
Scopolamine—Pruritus—Docetaxel—pancreatic cancer	0.000494	0.00145	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—pancreatic cancer	0.000491	0.00144	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000488	0.00143	CcSEcCtD
Scopolamine—Dry mouth—Epirubicin—pancreatic cancer	0.000481	0.00141	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—pancreatic cancer	0.00048	0.00141	CcSEcCtD
Scopolamine—Confusional state—Epirubicin—pancreatic cancer	0.000475	0.00139	CcSEcCtD
Scopolamine—Oedema—Epirubicin—pancreatic cancer	0.000471	0.00138	CcSEcCtD
Scopolamine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000462	0.00135	CcSEcCtD
Scopolamine—Dizziness—Docetaxel—pancreatic cancer	0.000462	0.00135	CcSEcCtD
Scopolamine—Tachycardia—Epirubicin—pancreatic cancer	0.00046	0.00135	CcSEcCtD
Scopolamine—Skin disorder—Epirubicin—pancreatic cancer	0.000458	0.00134	CcSEcCtD
Scopolamine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000456	0.00133	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000452	0.00132	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—pancreatic cancer	0.000445	0.0013	CcSEcCtD
Scopolamine—Vomiting—Docetaxel—pancreatic cancer	0.000444	0.0013	CcSEcCtD
Scopolamine—Rash—Docetaxel—pancreatic cancer	0.000441	0.00129	CcSEcCtD
Scopolamine—Hypotension—Epirubicin—pancreatic cancer	0.00044	0.00129	CcSEcCtD
Scopolamine—Dermatitis—Docetaxel—pancreatic cancer	0.00044	0.00129	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—pancreatic cancer	0.00044	0.00129	CcSEcCtD
Scopolamine—Headache—Docetaxel—pancreatic cancer	0.000438	0.00128	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—pancreatic cancer	0.000436	0.00128	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000428	0.00125	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—pancreatic cancer	0.000426	0.00125	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—pancreatic cancer	0.000424	0.00124	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000422	0.00124	CcSEcCtD
Scopolamine—Somnolence—Epirubicin—pancreatic cancer	0.000419	0.00123	CcSEcCtD
Scopolamine—Nausea—Docetaxel—pancreatic cancer	0.000415	0.00122	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—pancreatic cancer	0.000408	0.00119	CcSEcCtD
Scopolamine—Fatigue—Epirubicin—pancreatic cancer	0.000406	0.00119	CcSEcCtD
Scopolamine—Pain—Epirubicin—pancreatic cancer	0.000403	0.00118	CcSEcCtD
Scopolamine—Constipation—Epirubicin—pancreatic cancer	0.000403	0.00118	CcSEcCtD
Scopolamine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000388	0.00114	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—pancreatic cancer	0.000388	0.00114	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—pancreatic cancer	0.000376	0.0011	CcSEcCtD
Scopolamine—Pain—Doxorubicin—pancreatic cancer	0.000373	0.00109	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—pancreatic cancer	0.000373	0.00109	CcSEcCtD
Scopolamine—Body temperature increased—Epirubicin—pancreatic cancer	0.000373	0.00109	CcSEcCtD
Scopolamine—Abdominal pain—Epirubicin—pancreatic cancer	0.000373	0.00109	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000359	0.00105	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000345	0.00101	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000345	0.00101	CcSEcCtD
Scopolamine—Asthenia—Epirubicin—pancreatic cancer	0.000338	0.000991	CcSEcCtD
Scopolamine—Pruritus—Epirubicin—pancreatic cancer	0.000334	0.000977	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—pancreatic cancer	0.000313	0.000917	CcSEcCtD
Scopolamine—Dizziness—Epirubicin—pancreatic cancer	0.000312	0.000913	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—pancreatic cancer	0.000309	0.000904	CcSEcCtD
Scopolamine—Vomiting—Epirubicin—pancreatic cancer	0.0003	0.000878	CcSEcCtD
Scopolamine—Rash—Epirubicin—pancreatic cancer	0.000297	0.000871	CcSEcCtD
Scopolamine—Dermatitis—Epirubicin—pancreatic cancer	0.000297	0.00087	CcSEcCtD
Scopolamine—Headache—Epirubicin—pancreatic cancer	0.000295	0.000865	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—pancreatic cancer	0.000288	0.000845	CcSEcCtD
Scopolamine—Nausea—Epirubicin—pancreatic cancer	0.00028	0.00082	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—pancreatic cancer	0.000277	0.000812	CcSEcCtD
Scopolamine—Rash—Doxorubicin—pancreatic cancer	0.000275	0.000806	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—pancreatic cancer	0.000275	0.000805	CcSEcCtD
Scopolamine—Headache—Doxorubicin—pancreatic cancer	0.000273	0.0008	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—pancreatic cancer	0.000259	0.000759	CcSEcCtD
Scopolamine—CHRM5—Signaling by GPCR—CXCL8—pancreatic cancer	6.04e-05	0.000206	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TERT—pancreatic cancer	6.01e-05	0.000205	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	5.95e-05	0.000203	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	5.93e-05	0.000202	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	5.88e-05	0.0002	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	5.86e-05	0.0002	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	5.78e-05	0.000197	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	5.76e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TERT—pancreatic cancer	5.75e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—GCG—pancreatic cancer	5.75e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HIF1A—pancreatic cancer	5.74e-05	0.000196	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TSC2—pancreatic cancer	5.73e-05	0.000195	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—GCG—pancreatic cancer	5.73e-05	0.000195	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	5.7e-05	0.000195	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—GCG—pancreatic cancer	5.67e-05	0.000194	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—APOE—pancreatic cancer	5.61e-05	0.000191	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.59e-05	0.000191	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.57e-05	0.00019	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TYMS—pancreatic cancer	5.54e-05	0.000189	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.52e-05	0.000188	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HIF1A—pancreatic cancer	5.5e-05	0.000188	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KDR—pancreatic cancer	5.49e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TSC2—pancreatic cancer	5.49e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	5.48e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	5.47e-05	0.000186	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	5.41e-05	0.000185	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STK11—pancreatic cancer	5.41e-05	0.000184	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STK11—pancreatic cancer	5.39e-05	0.000184	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—APOE—pancreatic cancer	5.37e-05	0.000183	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STK11—pancreatic cancer	5.34e-05	0.000182	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.3e-05	0.000181	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KDR—pancreatic cancer	5.26e-05	0.000179	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NFKBIA—pancreatic cancer	5.23e-05	0.000178	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NOTCH1—pancreatic cancer	5.18e-05	0.000177	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	5.08e-05	0.000173	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	5.06e-05	0.000173	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CG—pancreatic cancer	5.06e-05	0.000173	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—NRAS—pancreatic cancer	5.06e-05	0.000173	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	5.01e-05	0.000171	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NFKBIA—pancreatic cancer	5e-05	0.000171	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EGF—pancreatic cancer	5e-05	0.000171	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NOTCH1—pancreatic cancer	4.96e-05	0.000169	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.87e-05	0.000166	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.86e-05	0.000166	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CG—pancreatic cancer	4.85e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—NRAS—pancreatic cancer	4.85e-05	0.000165	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.81e-05	0.000164	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EGF—pancreatic cancer	4.79e-05	0.000163	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	4.73e-05	0.000161	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	4.72e-05	0.000161	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	4.68e-05	0.00016	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	4.67e-05	0.000159	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	4.67e-05	0.000159	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	4.62e-05	0.000158	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HES1—pancreatic cancer	4.62e-05	0.000158	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—EGFR—pancreatic cancer	4.61e-05	0.000157	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HES1—pancreatic cancer	4.61e-05	0.000157	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HES1—pancreatic cancer	4.56e-05	0.000156	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CD44—pancreatic cancer	4.54e-05	0.000155	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—APOE—pancreatic cancer	4.51e-05	0.000154	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CD—pancreatic cancer	4.45e-05	0.000152	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	4.43e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—EGFR—pancreatic cancer	4.42e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	4.41e-05	0.000151	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.41e-05	0.00015	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	4.37e-05	0.000149	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—KRAS—pancreatic cancer	4.36e-05	0.000149	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—GCG—pancreatic cancer	4.35e-05	0.000148	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CD—pancreatic cancer	4.26e-05	0.000145	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	4.25e-05	0.000145	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	4.24e-05	0.000145	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.22e-05	0.000144	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	4.2e-05	0.000143	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—KRAS—pancreatic cancer	4.17e-05	0.000142	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—STK11—pancreatic cancer	4.09e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CG—pancreatic cancer	4.07e-05	0.000139	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TERT—pancreatic cancer	4.05e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TERT—pancreatic cancer	4.04e-05	0.000138	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PIK3CA—pancreatic cancer	4e-05	0.000137	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TERT—pancreatic cancer	4e-05	0.000136	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARG—pancreatic cancer	3.93e-05	0.000134	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CB—pancreatic cancer	3.88e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	3.87e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	3.86e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	3.86e-05	0.000132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	3.85e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	3.83e-05	0.000131	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	3.82e-05	0.00013	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	3.81e-05	0.00013	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—APOE—pancreatic cancer	3.78e-05	0.000129	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—APOE—pancreatic cancer	3.77e-05	0.000129	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—APOE—pancreatic cancer	3.73e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CXCL8—pancreatic cancer	3.73e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CB—pancreatic cancer	3.71e-05	0.000127	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KDR—pancreatic cancer	3.7e-05	0.000126	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HRAS—pancreatic cancer	3.7e-05	0.000126	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KDR—pancreatic cancer	3.69e-05	0.000126	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KDR—pancreatic cancer	3.66e-05	0.000125	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT1—pancreatic cancer	3.6e-05	0.000123	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CD—pancreatic cancer	3.58e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CXCL8—pancreatic cancer	3.57e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CASP3—pancreatic cancer	3.57e-05	0.000122	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HRAS—pancreatic cancer	3.55e-05	0.000121	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	3.52e-05	0.00012	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TYMS—pancreatic cancer	3.52e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	3.51e-05	0.00012	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	3.49e-05	0.000119	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	3.48e-05	0.000119	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	3.48e-05	0.000119	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCND1—pancreatic cancer	3.47e-05	0.000118	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT1—pancreatic cancer	3.45e-05	0.000118	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	3.44e-05	0.000118	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CTNNB1—pancreatic cancer	3.44e-05	0.000117	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CASP3—pancreatic cancer	3.42e-05	0.000117	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	3.41e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	3.41e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	3.4e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	3.4e-05	0.000116	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EGF—pancreatic cancer	3.37e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MMP9—pancreatic cancer	3.37e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	3.37e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	3.37e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EGF—pancreatic cancer	3.36e-05	0.000115	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTEN—pancreatic cancer	3.35e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EGF—pancreatic cancer	3.33e-05	0.000114	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCND1—pancreatic cancer	3.32e-05	0.000113	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CTNNB1—pancreatic cancer	3.29e-05	0.000112	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT1—pancreatic cancer	3.27e-05	0.000112	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MMP9—pancreatic cancer	3.23e-05	0.00011	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTEN—pancreatic cancer	3.21e-05	0.000109	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT1—pancreatic cancer	3.13e-05	0.000107	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CB—pancreatic cancer	3.12e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	3.11e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SRC—pancreatic cancer	3.11e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	3.1e-05	0.000106	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—pancreatic cancer	3.09e-05	0.000105	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	3.07e-05	0.000105	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—VEGFA—pancreatic cancer	3.03e-05	0.000103	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	3e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—STAT3—pancreatic cancer	3e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	2.99e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NRAS—pancreatic cancer	2.99e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SRC—pancreatic cancer	2.98e-05	0.000102	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.97e-05	0.000101	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.96e-05	0.000101	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	2.96e-05	0.000101	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	2.94e-05	0.0001	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.93e-05	0.0001	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	2.93e-05	9.99e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	2.9e-05	9.89e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—VEGFA—pancreatic cancer	2.9e-05	9.89e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—STAT3—pancreatic cancer	2.87e-05	9.79e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NRAS—pancreatic cancer	2.86e-05	9.77e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—APOE—pancreatic cancer	2.86e-05	9.76e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MYC—pancreatic cancer	2.78e-05	9.5e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TGFB1—pancreatic cancer	2.78e-05	9.48e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—EGFR—pancreatic cancer	2.72e-05	9.29e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.7e-05	9.2e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTEN—pancreatic cancer	2.69e-05	9.19e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	2.69e-05	9.18e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MYC—pancreatic cancer	2.67e-05	9.1e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.66e-05	9.09e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TGFB1—pancreatic cancer	2.66e-05	9.07e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	2.61e-05	8.92e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	2.61e-05	8.9e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	2.61e-05	8.89e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.58e-05	8.81e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	2.58e-05	8.8e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KRAS—pancreatic cancer	2.57e-05	8.78e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	2.51e-05	8.57e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	2.5e-05	8.54e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	2.5e-05	8.52e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARG—pancreatic cancer	2.49e-05	8.5e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	2.49e-05	8.49e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	2.48e-05	8.46e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	2.46e-05	8.41e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	2.46e-05	8.41e-05	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	2.43e-05	8.28e-05	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	2.42e-05	8.25e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	2.41e-05	8.2e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	2.4e-05	8.18e-05	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	2.4e-05	8.17e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	2.37e-05	8.1e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PIK3CA—pancreatic cancer	2.36e-05	8.06e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	2.34e-05	7.99e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	2.33e-05	7.96e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	2.32e-05	7.91e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	2.31e-05	7.88e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	2.31e-05	7.88e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	2.29e-05	7.81e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—pancreatic cancer	2.29e-05	7.8e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	2.27e-05	7.75e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.27e-05	7.74e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	2.27e-05	7.73e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	2.26e-05	7.72e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	2.26e-05	7.71e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	2.25e-05	7.68e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	2.24e-05	7.65e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	2.23e-05	7.61e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	2.2e-05	7.52e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	2.2e-05	7.5e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—pancreatic cancer	2.19e-05	7.47e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	2.19e-05	7.46e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	2.18e-05	7.42e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SRC—pancreatic cancer	2.1e-05	7.15e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	2.09e-05	7.14e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SRC—pancreatic cancer	2.09e-05	7.13e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SRC—pancreatic cancer	2.07e-05	7.06e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	2.04e-05	6.96e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	2.03e-05	6.94e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	2.02e-05	6.89e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	2.02e-05	6.88e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	2.01e-05	6.87e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	2.01e-05	6.87e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	2.01e-05	6.85e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	1.99e-05	6.8e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	1.99e-05	6.79e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.98e-05	6.75e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.96e-05	6.69e-05	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	1.93e-05	6.59e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PIK3CA—pancreatic cancer	1.9e-05	6.48e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MYC—pancreatic cancer	1.88e-05	6.41e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	1.87e-05	6.39e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MYC—pancreatic cancer	1.87e-05	6.38e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	1.87e-05	6.37e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MYC—pancreatic cancer	1.85e-05	6.32e-05	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	1.85e-05	6.31e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	1.85e-05	6.31e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	1.84e-05	6.26e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	1.83e-05	6.25e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	1.81e-05	6.18e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	1.74e-05	5.92e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	1.73e-05	5.9e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	1.71e-05	5.84e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTEN—pancreatic cancer	1.71e-05	5.83e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	1.59e-05	5.44e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	1.59e-05	5.42e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	1.57e-05	5.37e-05	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKT1—pancreatic cancer	1.55e-05	5.3e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—pancreatic cancer	1.54e-05	5.26e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—pancreatic cancer	1.54e-05	5.24e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—pancreatic cancer	1.52e-05	5.19e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	1.47e-05	5.03e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	1.47e-05	5.01e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	1.46e-05	4.97e-05	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	1.3e-05	4.44e-05	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	1.3e-05	4.43e-05	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	1.29e-05	4.38e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.21e-05	4.11e-05	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKT1—pancreatic cancer	9.85e-06	3.36e-05	CbGpPWpGaD
